Damante, Mark A.
Juncker, Ryan B.
Little, Andrew S.
Van Gompel, Jamie J.
Palit, Sandhya
Pacione, Donato R.
Barkhoudarian, Garni
Sivakumar, Walavan
Blackburn, Spiros
Mendoza, Michelle MagaƱa
Evans, James J.
Benjamin, Carolina
Palmer, Joshua D.
Giglio, Pierre
Prevedello, Daniel M.
Wu, Kyle C.
,
Article History
Received: 10 June 2026
Accepted: 30 July 2026
First Online: 14 August 2026
Declarations
Ethics approval: This retrospective study was performed in line with the principles of the declaration of Helsinki. Approval was granted by the ethics committee at The Ohio State University Biomedical Institutional Review Board (#2022H0179). The overarching multi-institutional IRB oversight was provided by the Institutional Review Board at Barrow Neurological Institute.
Competing interests: J.J.E. is a consultant for and has received royalties from Mizuho. G.B. has received consulting fees from Cerevasc Inc., SpiWay Inc., and Zeiss Corp. J.V.G. is a named inventor on intellectual property licensed to Cadence Neuroscience Inc. D.M.P. has received consulting fees from Leica, Stryker, BK Medical, and KLS Martin. K.C.W. has received consulting fees from Retromer Therapeutics and acts as an advisor with stock ownership to Zeta Surgical. None of these disclosures apply or are relevant to the presented work. All remaining authors have no relevant financial or non-financial interests to disclose.